Roivant Sciences Ltd.
ROIV· Nasdaq
ROIVRoivant Sciences Ltd.
Filed Aug 15, 2022 · 10-Q · 46 days after period end · 0001193125-22-220561
| Metric | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|
| Revenue | $4.32M | $7.74M | $1.58M |
| Net Income | -$331.81M | -$82.18M | -$3.24M |
| EPS Diluted | -$0.48 | -$0.13 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Roivant Sciences Ltd. · CIK 1635088 · Engraved from SEC EDGAR
ended Jun 30, 2022 · filed Aug 15, 2022 · 46 d after period end
